EU lists rare nerve disorder as side-effect of J&J COVID-19 vaccine

Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration

July 22 (Reuters) – Europe’s medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson’s (JNJ.N) COVID-19 vaccine after it reviewed 108 cases reported worldwide.

“After assessing the available data, PRAC considered that a causal relationship between COVID-19 vaccine Janssen and GBS is possible,” the European Medicines Agency said, referring to its safety committee, PRAC.

Reporting by Pushkala Aripaka in Bengaluru; editing by Uttaresh.V

Our Standards: The Thomson Reuters Trust Principles.

Read More

Written by 

Leave a Reply

Your email address will not be published. Required fields are marked *